Latest Breaking News On - Vilaseca cabo - Page 1 : vimarsana.com

TAR-210 was safe and showed promising clinical activity in patients with FGFR-altered high- and intermediate-risk non–muscle-invasive bladder cancer.

United statesComunidad autonoma de catalunaVilaseca caboUrology serviceAmerican urological association annual meetingUrological association annualBacillus calmette guFgfr altered non muscle invasive bladder cancerNon muscle invasive bladder cancer2024 american urological association annual meeting2024 aua annual meetingTar 210Erdafitinib intravesical delivery system